- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 147.56M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 157.01M sh |
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 148.81M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $90.99M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $59.03M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $908.5M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $959.55M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $395.66M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $367.9M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $950.77M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $903.52M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $228.05M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $227.31M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.86B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.86B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $91.35M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $126.23M |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $32.89M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.6M |
| Capex | Q1 2025 · Mar 31, 2024 | $15.88M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $33.15M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $10.27M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.75M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $11.13M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $253.98M |
| Revenue | Q1 2025 · Mar 31, 2024 | $275.37M |